BOTOX for TMD: questions about evidence, risks, and off-label use

What "off-label" means

Approved medicines may be prescribed for uses outside their label at a clinician's judgment. The label for botulinum toxin covers conditions such as chronic migraine prevention and certain muscle disorders; it does not include TMD or bruxism. Off-label use is legal and common, but it means the evidence and safety data for that use are less complete.

What the evidence shows

Systematic reviews and meta-analyses disagree. Some report modest short-term pain reduction in myogenous TMD compared with placebo; others find no significant difference. Effects on mouth opening are generally absent. Studies are small, short and heterogeneous, so certainty is low to moderate. The National Institute of Dental and Craniofacial Research recommends conservative, reversible treatments first for TMD (NIDCR).

Risks reported

Temporary chewing weakness, changes in smile or facial expression if nearby muscles are affected, bruising, and, with repeated injections, reports of reduced bone density in the jaw in some imaging studies. Effects wear off over months, so treatment is repeated.

Questions to ask

• Have I tried reversible care long enough: habit change, exercises, a guard, physician-managed pain relief?
• What result do you expect for my pattern, and over what period?
• What are the risks for me, including to chewing and expression?
• Who injects, and what is their training?
• How will we judge whether it helped, and when would we stop?
• Has my physician been involved?

What this page does not say

It does not recommend for or against; it does not state fees; and it does not describe any service as offered at a particular practice. Decisions belong in a consultation with both clinicians.

Next step: Request a consultation or call (805) 565-5111. A request is not a confirmed appointment; the office confirms times during its listed hours (Monday to Thursday, 8 am to 5 pm, plus select Fridays).